JP2018529625A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529625A5 JP2018529625A5 JP2017551585A JP2017551585A JP2018529625A5 JP 2018529625 A5 JP2018529625 A5 JP 2018529625A5 JP 2017551585 A JP2017551585 A JP 2017551585A JP 2017551585 A JP2017551585 A JP 2017551585A JP 2018529625 A5 JP2018529625 A5 JP 2018529625A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- peptide
- seq
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562219900P | 2015-09-17 | 2015-09-17 | |
| US62/219,900 | 2015-09-17 | ||
| PCT/US2016/052131 WO2017049082A2 (en) | 2015-09-17 | 2016-09-16 | Compositions comprising pregnancy specific glycoproteins and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018529625A JP2018529625A (ja) | 2018-10-11 |
| JP2018529625A5 true JP2018529625A5 (enExample) | 2019-10-17 |
Family
ID=58289625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017551585A Pending JP2018529625A (ja) | 2015-09-17 | 2016-09-16 | 妊娠特異的糖タンパク質を含む組成物及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11007249B2 (enExample) |
| EP (1) | EP3261722B1 (enExample) |
| JP (1) | JP2018529625A (enExample) |
| AU (1) | AU2016323769B2 (enExample) |
| CA (1) | CA2981191C (enExample) |
| WO (1) | WO2017049082A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022219008A1 (en) | 2021-04-14 | 2022-10-20 | University College Cork - National University Of Ireland, Cork | Treatment of cerebrovascular events and neurological disorders |
| JP2024514194A (ja) | 2021-04-14 | 2024-03-28 | ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク | 変形性関節症の治療に使用するためのｐｓｇ１ |
| WO2024078729A1 (en) | 2022-10-14 | 2024-04-18 | University College Cork - National University Of Ireland, Cork | Placenta expressed proteins for use in the treatment of tendon injury |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP0154316B1 (en) | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
| EP0401384B1 (en) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
| US5169835A (en) | 1989-01-18 | 1992-12-08 | Oklahoma Medical Research Foundation | Pregancy specific proteins applications |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| EP1578366A4 (en) * | 2002-10-09 | 2007-12-19 | Tolerrx Inc | MOLECULES PREFERABLY ASSOCIATED WITH EFFECTOR T CELLS OR REGULATORY T CELLS AND METHODS OF USE THEREOF |
| US9005616B2 (en) | 2009-08-31 | 2015-04-14 | Amplimmune, Inc. | Methods and compositions for the inhibition of transplant rejection |
-
2016
- 2016-09-16 AU AU2016323769A patent/AU2016323769B2/en active Active
- 2016-09-16 JP JP2017551585A patent/JP2018529625A/ja active Pending
- 2016-09-16 US US15/561,622 patent/US11007249B2/en not_active Ceased
- 2016-09-16 EP EP16847381.7A patent/EP3261722B1/en active Active
- 2016-09-16 CA CA2981191A patent/CA2981191C/en active Active
- 2016-09-16 WO PCT/US2016/052131 patent/WO2017049082A2/en not_active Ceased
- 2016-09-16 US US18/319,314 patent/USRE50535E1/en active Active